進階搜尋


下載電子全文  
系統識別號 U0026-0808201313271800
論文名稱(中文) 植物鹼 CIL-102 抗神經癌活性之研究
論文名稱(英文) Studies of CIL-102 (1-[4-(furo[2,3-b]quinolin-4-ylamino)phenyl]ethanone) antitumor mechanisms and effects on gliomas
校院名稱 成功大學
系所名稱(中) 基礎醫學研究所
系所名稱(英) Institute of Basic Medical Sciences
學年度 101
學期 2
出版年 102
研究生(中文) 鄧志娟
研究生(英文) Chih-Chuan Teng
學號 S58951332
學位類別 博士
語文別 英文
論文頁數 97頁
口試委員 召集委員-簡伯武
口試委員-辛致煒
口試委員-周楠華
指導教授-司君一
口試委員-鄭授德
口試委員-陳政男
中文關鍵字 神經膠質瘤  植物化學物質  細胞週期  凋亡  轉移 
英文關鍵字 GBM  CIL-102  cell cycle  apoptosis  meastasis 
學科別分類
中文摘要 神經膠質瘤(GBM),是種常見的惡性腫瘤,具有快速生長、易侵犯周邊組織的特性,因此在治療上較為困難,且復發率高。儘管醫學界一直積極的在尋找有效的治療方法,但是一直都遇到困難。在現今的癌症研究上,一些替代醫學(alternative medicine)提供了一些新的醫療選擇。就日前而言,化學預防(Chemoprevention);利用自然的食物成分或合成的化學因子,例如植物化學物質(phytochemicals),提供了有效的預防策略,針對抑制、延緩或回覆人類的癌化過程(carcinogenesis)。在這些植物化學物質中,多酚類(polyphenols)是一個大宗。不管在體外或體內的實驗中,均證明這些多酚類能有效的抵抗各種不同種類的癌症。CIL-102 (1-[4-(furo[2,3-b]quinolin-4-ylamino)phenyl]ethanone),來自於Camptotheca acuminata樹皮或莖(一種原生於中國的樹木)的一種生物鹼camptothecin之合成衍生物。針對特定的癌症而言,已知具有一些藥理功效,包括抗癌(anticancer)和促進細胞凋亡(apoptosis)。我們的實驗主要是針對神經膠質瘤的多樣性,希望提供植物鹼 CIL-102 抗神經癌活性之研究。在第一部分實驗中,我們發現CIL-102會因為影響reactive oxygen species (ROS)的生成;增加ROS的量,進而造成extracellular signal-related kinase (ERK1/2)磷酸化,降低細胞周期(cell cycle)相關蛋白表現 (cyclin A, cyclin B, cyclin D1, and cdk1),和磷酸化cdk1Tyr15 、 Cdc25cSer216,導致神經膠質瘤細胞的細胞周期停滯在G2/M期,最後引起神經膠質瘤細胞的死亡。接著,在第二部分,我們同時間發現,CIL-102會影響神經膠質瘤細胞的轉移能力(invasive)。透過蛋白質體學(proteomic approach)方法,我們找到更多CIL-102處理後,神經膠質瘤細胞上出現許多不同蛋白的表現。從實驗中發現,由於ROS的增加表現、引起JNK1/2 and p70S6K磷酸化,最後引起FUMH (Fumarate hydratase)增加表現,造成細胞的凋亡和抑制其轉移能力。從兩部分實驗中證明,CIL-102對神經膠質瘤細胞來說,一方面可以抑制癌細胞增生,另一方面又可抑制癌細胞的轉移。因此在治療神經膠質上應該是有一些程度的療效,能提供在未來神經膠質瘤的治療上,另一種選擇。最後,在第二部分實驗中,我們亦見到神經膠質瘤細胞在CIL-102處理後,還有許多不同的蛋白質表現差異,如Translationally-controlled tumor protein (TCTP)、Stathmin (STMN1)、Hypoxia up-regulated protein 1 (HYOU1) 和 Nucleophosmin (NPM)等,值得我們接下來對CIL-102的抗癌活性做更進一步的探討。
英文摘要 Low-grade diffuse gliomas WHO grade II (diffuse astrocytoma, oligoastrocytoma, oligodendroglioma), one of the most common malignant tumors, fast-growing, invasive, difficult to treat, and are likely to recur in worldwide. Despite intense efforts to develop treatments, effective agents are still not available. Complementary and alternative medicine tempts many efforts for new drug discovery in current cancer research. Chemoprevention is an active cancer preventive strategy to inhibit, delay or reverse human carcinogenesis, using naturally extracting or synthetic chemical agents, such as various phytochemicals. Among these phytochemicals, polyphenols are the largest in quantity among the phytochemicals. Several hundred scientific studies in the vitro or in the vivo all suggest a protective role of these dietary polyphenols against different types of cancer. CIL-102 (1-[4-(furo[2,3-b]quinolin-4-ylamino)phenyl]ethanone) is the major active agent of the alkaloid derivative of Camptotheca acuminata with multiple pharmacological activities, including anticancer effects and promotion of apoptosis.
The aims of research are to study the mechanism of CIL-102 affections on GBM cell lines. In our data, first, we found that the molecular mechanisms by which CIL-102 affects the generation of reactive oxygen species (ROS) and cell cycle G2/M arrest in glioma cells. Treatment of U87 cells with 1.0 µM CIL-102 resulted in phosphorylation of extracellular signal-related kinase (ERK1/2), downregulation of cell cycle-related proteins (cyclin A, cyclin B, cyclin D1, and cdk1), and phosphorylation of cdk1Tyr15 and Cdc25cSer216. Second, our results demonstrate that CIL-102 treatment of U87 cells results in decreased cell proliferation and invasiveness. Sustain phosphorylation of JNK1/2 and p70S6K, generation of the reactive oxygen species as well as up-regulating the levels of FUMH (Fumarate hydratase) inducing CIL-102 dose-dependent induction of apoptosis and inhibitory invasiveness. At last, by Proteomic approaches showed the significant differences in protein expression profiles in U87 cells upon CIL-102 treatments. It needs to be further study other differential proteins whether mediated actions in CIL-102 cultured cells.
論文目次 CONTENTS
LIST OF FIGURES 1
CHAPTER 1 INTRODUCTION 3
1.1. BACKGROUND 3
1.2. THE AIMS OF THE RESEARCH 15
CHAPTER 2 19
The inhibitory effect of CIL-102 on the growth of human astrocytoma cells is mediated by the generation of reactive oxygen species and induction of ERK1/2 MAPK
2.1. INTRODUCTION 20
2.2. MATERIALS AND METHODS 23
2.2.1. Chemical reagents and antibodies 23
2.2.2. Cell culture 23
2.2.3. Cell growth and proliferation assay 24
2.2.4. Apoptosis assay and cell cycle distribution analysis 24
2.2.5. Preparation of total cell extracts and immunoblot analyses 25
2.2.6. Measurement of ROS 25
2.2.7. Statistical analysis 26
2.3. RESULT 27
2.3.1. Effects of CIL-102 on the viability of human astrocytoma cells 27
2.3.2. CIL-102 induces G2/M arrest in U87 cells 27
2.3.3. Involvement of ROS generation in CIL-102-inhibited cell proliferation 28
2.3.4. ROS and the Ras/ERK1/2 triggering pathway are involved in the regulation of CIL-102-induced G2/M arrest in U87 cells 28
2.3.5. Activation of ERK1/2 signaling pathway by CIL-102 in U87 cells 29
2.3.6. Effects of CIL-102 on the expression of Cdc25cSer216 and cell cycle related proteins in U87 cells 29
2.3.7. Regulation of the expression of cyclin A and cyclin B by ERK1/2 and Cdc25c 30
2.4. DISCUSSION 31
2.5. FIGURE LEGENDS 34
CHAPTER 3 41
Quantitative proteomic analysis to the inhibitory effects of CIL-102 viability and invasiveness in human glioma cells
3.1. INTRODUCTION 42
3.2. MATERIALS AND METHODS 45
3.2.1. Cell culture 45
3.2.2. Chemical Reagents and Antibodies 45
3.2.3. Assessment of cell viability and apoptosis assay 46
3.2.4. Scratch assays 47
3.2.5. Boyden chamber assay 47
3.2.6. Second dimensional protein electrophoresis analysis of U87 cells proteomic profiles 48
3.2.7. In-gel digestion and identification of peptide fingerprints of with or without CIL-102 treatment using MALDI-TOF 49
3.2.8. Preparation of total cell extracts and immunoblot analyses 50
3.2.9. shRNA Lentivirus transfection 50
3.2.10. Measurement of reactive oxygen species 50
3.2.11. Statistical Analysis 51
3.3. RESULT 52
3.3.1. Anti-cancer activity of CIL-102 upon human astrocytoma cells 52
3.3.2. Proteomic profiling of U87 glioma cells treated with CIL-102 53
3.3.3. Validation of the differential proteins 2D results by western blotting 54
3.3.4. Functional validation of CIL-102 induced JNK 1/2 and mTOR signaling pathways as well as reactive oxygen species on apoptosis and invasion by knockdown of FUMH with short hairpin RNA (shRNA) in U87 cells 55
3.3.5. ROS generation and FUMH are involved in the regulation of the caspases and HIF1, MMP2 and MT1-MMP levels by CIL-102 in U87 cells 56
3.4. DISCUSSION 58
3.5. FIGURE LEGEND 58
CHAPTER4 73
Drugs with similar antitumor mechanism to CIL-102, and potential usefulness of CIL-102 as an alternative for cancer therapy
REFERENCES 83

參考文獻 Ames, B. N., & Gold, L. S. (1991). Endogenous mutagens and the causes of aging and cancer. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 250(1), 3-16.
Avgeropoulos, N. G., & Batchelor, T. T. (1999). New treatment strategies for malignant gliomas. The Oncologist, 4(3), 209-224.
Bastianetto, S., Zheng, W. H., & Quirion, R. (2000). Neuroprotective abilities of resveratrol and other red wine constituents against nitric oxide‐related toxicity in cultured hippocampal neurons. British journal of pharmacology, 131(4), 711-720.
Beth Furnari, A. B., Michael N. Boddy, Clare H. McGowan,, & Russell*, a. P. (1999). Cdc25 Inhibited In Vivo and In Vitro by Checkpoint Kinases Cds1 and Chk1. Molecular Biology of the Cell, 10, 833-845.
Brábek, J., Mierke, C. T., Rösel, D., Veselý, P., & Fabry, B. (2010). The role of the tissue microenvironment in the regulation of cancer cell motility and invasion. Cell Commun Signal, 8, 22.
Bravo, L. (2009). Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutrition reviews, 56(11), 317-333.
Castedo, M., Perfettini, J. L., Roumier, T., Andreau, K., Medema, R., & Kroemer, G. (2004). Cell death by mitotic catastrophe: a molecular definition. Oncogene, 23(16), 2825-2837.
Chen, I. L., Chen, Y.L.,Tzeng, C.C., (2003). An efficient synthesis of antitumor 4-anilinofuro. The Chinese Pharmaceutical Journal, 55, 49-53.
Chen, T. C., Tsai, J. P., Huang, H. J., Teng, C. C., Chien, S. J., Kuo, H. C., Chen, C. N. (2011). Regulation of cyclooxygenase‐2 expression in human bladder epithelial cells infected with type I fimbriated uropathogenic E. coli. Cellular microbiology, 13(11), 1703-1713.
Chen, Y. L., Chen, I. L., Wang, T. C., Han, C. H., & Tzeng, C. C. (2005). Synthesis and anticancer evaluation of certain 4-anilinofuro[2,3-b]quinoline and 4-anilinofuro[3,2-c]quinoline derivatives. Eur J Med Chem, 40(9), 928-934.
Cheynier, V. (2005). Polyphenols in foods are more complex than often thought. The American journal of clinical nutrition, 81(1), 223S-229S.
Chiu, Y. W., Lin, T. H., Huang, W. S., Teng, C. Y., Liou, Y. S., Kuo, W. H., Kuo, H. C. (2011). Baicalein inhibits the migration and invasive properties of human hepatoma cells. Toxicol Appl Pharmacol, 255(3), 316-326.
Collins, I., & Garrett, M. D. (2005). Targeting the cell division cycle in cancer: CDK and cell cycle checkpoint kinase inhibitors. Current opinion in pharmacology, 5(4), 366-373.
Crespo-Ortiz, M. P., & Wei, M. Q. (2011). Antitumor activity of artemisinin and its derivatives: from a well-known antimalarial agent to a potential anticancer drug. Journal of Biomedicine and Biotechnology, 2012.
Cuevas, B. D., Abell, A. N., & Johnson, G. L. (2007). Role of mitogen-activated protein kinase kinase kinases in signal integration. Oncogene, 26(22), 3159-3171.
Cushing, H. (1932). Intracranial tumours. The Journal of Nervous and Mental Disease, 76(5), 539.
D'Incalci, M., Steward, W. P., & Gescher, A. J. (2005). Use of cancer chemopreventive phytochemicals as antineoplastic agents. The lancet oncology, 6(11), 899-904.
David N. Louis, H. O., Otmar D. Wiestler, Webster K. Cavenee, Peter C. Burger, Anne Jouvet, Bernd W. Scheithauer, and Paul Kleihues. (2007). The 2007 WHO ClassiWcation of Tumours of the Central Nervous System. 114, 97-105.
Davis, F. G., Freels, S., Grutsch, J., Barlas, S., & Brem, S. (1998). Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991. Journal of neurosurgery, 88(1), 1-10.
Dhandapani, K. M., Mahesh, V. B., & Brann, D. W. (2007). Curcumin suppresses growth and chemoresistance of human glioblastoma cells via AP‐1 and NFκB transcription factors. Journal of neurochemistry, 102(2), 522-538.
Dohrmann, G. J., Farwell, J. R., & Flannery, J. T. (1976). Glioblastoma multiforme in children. Journal of neurosurgery, 44(4), 442-448.
Dunn, G. P., Rinne, M. L., Wykosky, J., Genovese, G., Quayle, S. N., Dunn, I. F., Wang, A. (2012). Emerging insights into the molecular and cellular basis of glioblastoma. Genes & Development, 26(8), 756-784.
Fadeel, B., & Orrenius, S. (2005). Apoptosis: a basic biological phenomenon with wide‐ranging implications in human disease. Journal of internal medicine, 258(6), 479-517.
Gali-Muhtasib, H., & Bakkar, N. (2002). Modulating cell cycle: current applications and prospects for future drug development. Current cancer drug targets, 2(4), 309-336.
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of cancer: the next generation. Cell, 144(5), 646-674.
Harborne, J. B., & Williams, C. A. (2000). Advances in flavonoid research since 1992. Phytochemistry, 55(6), 481-504.
Hart, I. R., & Fidler, I. J. (1980a). Cancer invasion and metastasis. Quarterly Review of Biology, 121-142.
Hart, I. R., & Fidler, I. J. (1980b). Role of organ selectivity in the determination of metastatic patterns of B16 melanoma. Cancer research, 40(7), 2281-2287.
Herceg, Z., & Hainaut, P. (2007). Genetic and epigenetic alterations as biomarkers for cancer detection, diagnosis and prognosis. Molecular oncology, 1(1), 26.
Hsu, W. H., Hsieh, Y. S., Kuo, H. C., Teng, C. Y., Huang, H. I., Wang, C. J., Kuo, W. H. (2007). Berberine induces apoptosis in SW620 human colonic carcinoma cells through generation of reactive oxygen species and activation of JNK/p38 MAPK and FasL. Arch Toxicol, 81(10), 719-728.
Hu, M. L. (2011). Dietary polyphenols as antioxidants and anticancer agents: more questions than answers. Chang Gung Med J, 34(5), 449-446O.
Huang, Y. T., Huang, D. M., Guh, J. H., Chen, I. L., Tzeng, C. C., & Teng, C. M. (2005). CIL-102 interacts with microtubule polymerization and causes mitotic arrest following apoptosis in the human prostate cancer PC-3 cell line. J Biol Chem, 280(4), 2771-2779.
Huffman, M. A. (2003). Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proceedings of the Nutrition Society, 62(2), 371-382.
Hung, S.-H., Shen, K.-H., Wu, C.-H., Liu, C.-L., & Shih, Y.-W. (2009). α-Mangostin suppresses PC-3 human prostate carcinoma cell metastasis by inhibiting matrix metalloproteinase-2/9 and urokinase-plasminogen expression through the JNK signaling pathway. Journal of agricultural and food chemistry, 57(4), 1291-1298.
I-Li Chen, Y.-L. C., Cherng-Chyi Tzeng, Ih-Sheng Chen. (2002). Synthesis and cytotoxic evaluation of some 4-Anilinofuro[2,3-b]quinoline derivatives. Helvetica Chimica Acta, 85, 2214-2221.
Iacob, G., & Dinca, E. B. (2009a). Current data and strategy in glioblastoma multiforme. Journal of medicine and life, 2(4), 386.
Iacob, G., & Dinca, E. B. (2009b). Current data and strategy in glioblastoma multiforme Current data and strategy in glioblastoma multiforme.

Kapoor, G. S., & O’Rourke, D. M. (2003). Receptor tyrosine kinase signaling in gliomagenesis: pathobiology and therapeutic approaches. Cancer Biology & Therapy, 2(4), 331-343.
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. British journal of cancer, 26(4), 239.
Kitange, G. J., Templeton, K. L., & Jenkins, R. B. (2003). Recent advances in the molecular genetics of primary gliomas. Current opinion in oncology, 15(3), 197-203.
Kleihues, P., & Cavenee, W. K. (2000). Pathology and genetics of tumours of the nervous system: International Agency for Research on Cancer.
Korr, H. (1987). PROLlFERATlON AND CELL CYCLE PARAMETERS OF ASTROCYTES. Astrocytes Pt 3: Biochemistry, Physiology, and Pharmacology of Astrocytes, 77.
Kuo, H. C., Kuo, W. H., Lee, Y. J., Wang, C. J., & Tseng, T. H. (2006). Enhancement of caffeic acid phenethyl ester on all-trans retinoic acid-induced differentiation in human leukemia HL-60 cells. Toxicol Appl Pharmacol, 216(1), 80-88.
Kwon, K. H., Barve, A., Yu, S., HUANG, M. T., & KONG, A. N. T. (2007). Cancer chemoprevention by phytochemicals: potential molecular targets, biomarkers and animal models1. Acta Pharmacol Sin, 28(9), 1409-1421.
Kyriakis JM, A. J. (2001). Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol Rev., 81, 807-869.
Le, X. F., Hittelman, W. N., Liu, J., McWatters, A., Li, C., Mills, G. B., & Bast, R. C., Jr. (2003). Paclitaxel induces inactivation of p70 S6 kinase and phosphorylation of Thr421 and Ser424 via multiple signaling pathways in mitosis. Oncogene, 22(4), 484-497.
Lefranc, F., Brotchi, J., & Kiss, R. (2005). Possible future issues in the treatment of glioblastomas: special emphasis on cell migration and the resistance of migrating glioblastoma cells to apoptosis. Journal of clinical oncology, 23(10), 2411-2422.
Li-Weber, M. (2010). Targeting apoptosis pathways in cancer by Chinese medicine. Cancer Lett.
Lima, F. R., Kahn, S. A., Soletti, R. C., Biasoli, D., Alves, T., da Fonseca, A. C. C., Holanda-Afonso, R. (2012). Glioblastoma: Therapeutic challenges, what lies ahead. Biochimica et Biophysica Acta (BBA)-Reviews on Cancer, 1826(2), 338-349.
Liu, R. H. (2004). Potential synergy of phytochemicals in cancer prevention: mechanism of action. The Journal of nutrition, 134(12), 3479S-3485S.
Loo, G. (2003). Redox-sensitive mechanisms of phytochemical-mediated inhibition of cancer cell proliferation11G.
Loo, K. Takahashi, A. Powolny, R.A. Hopkins, Induction of GADD45 gene expression by phenylethyl isothiocyanate in HCT-116 human colon adenocarcinoma cells, FASEB J 16 (2002) A264-A265. Also, unpublished data. (review). The Journal of Nutritional Biochemistry, 14(2), 64-73.
LoTempio, M. M., Veena, M. S., Steele, H. L., Ramamurthy, B., Ramalingam, T. S., Cohen, A. N., Wang, M. B. (2005). Curcumin suppresses growth of head and neck squamous cell carcinoma. Clinical cancer research, 11(19), 6994-7002.
Louis, D. N. (2006). Molecular pathology of malignant gliomas. Annu. Rev. Pathol. Mech. Dis., 1, 97-117.
Mallory, F. B. (1915). The Principles of Pathologic Histology. Southern Medical Journal, 8(2), 164.
Manson, M. M. (2003). Cancer prevention–the potential for diet to modulate molecular signalling. Trends in molecular medicine, 9(1), 11-18.
Mareel, M., Oliveira, M. J., & Madani, I. (2009). Cancer invasion and metastasis: interacting ecosystems. Virchows Archiv, 454(6), 599-622.
Mattson, M. P., & Cheng, A. (2006). Neurohormetic phytochemicals: Low-dose toxins that induce adaptive neuronal stress responses. Trends in neurosciences, 29(11), 632-639.
Melchini, A., & Traka, M. H. (2010). Biological profile of erucin: a new promising anticancer agent from cruciferous vegetables. [Review]. Toxins (Basel), 2(4), 593-612.
Melissa R. Kelly, J. X., Karen E. Alexander, George Loo. (2001). Disparate effects of similar phenolic phytochemicals as inhibitors of oxidative damage to cellular DNA. Mutation Res., 485, 309-318.
Meloche, S., & Pouyssegur, J. (2007). The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition. Oncogene, 26(22), 3227-3239.
Minniti, G., Muni, R., Lanzetta, G., Marchetti, P., & Enrici, R. M. (2009). Chemotherapy for glioblastoma: current treatment and future perspectives for cytotoxic and targeted agents. Anticancer research, 29(12), 5171-5184.
Mollinedo F, G. C. (2003). Microtubules, microtubule-interfering agents and apoptosis. Apoptosis., 8, 413-450.
Mueller PR, C. T., Kumagai A, Dunphy WG. (1995). Myt1: a membrane-associated inhibitory kinase that phosphorylates Cdc2 on both threonine-14 and tyrosine-15. Science., 270, 86-90.
Nicolson, G. L. (1988). Organ specificity of tumor metastasis: role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer and Metastasis Reviews, 7(2), 143-188.
O'Brien, M. A., & Kirby, R. (2008). Apoptosis: A review of pro‐apoptotic and anti‐apoptotic pathways and dysregulation in disease. Journal of Veterinary Emergency and Critical Care, 18(6), 572-585.
Ogretmen, B., & Hannun, Y. A. (2004). Biologically active sphingolipids in cancer pathogenesis and treatment. Nature Reviews Cancer, 4(8), 604-616.
Pan, M. H., & Ho, C. T. (2008). Chemopreventive effects of natural dietary compounds on cancer development. Chem. Soc. Rev., 37(11), 2558-2574.
Parkin, D. M. (2001). Global cancer statistics in the year 2000. The lancet oncology, 2(9), 533-543.
Ramos, S. (2007). Effects of dietary flavonoids on apoptotic pathways related to cancer chemoprevention. The Journal of nutritional biochemistry, 18(7), 427-442.
Ramos, S. (2008). Cancer chemoprevention and chemotherapy: dietary polyphenols and signalling pathways. Molecular nutrition & food research, 52(5), 507-526.
Reardon, D. A., & Wen, P. Y. (2006). Therapeutic advances in the treatment of glioblastoma: rationale and potential role of targeted agents. The Oncologist, 11(2), 152-164.
Ren, F., Zhang, S., Mitchell, S. H., Butler, R., & Young, C. Y. (2000). Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells. Oncogene, 19(15), 1924-1932.
Richard S. Morrison, F. Y., Hideyuki Saya, Janet M. Bruner, Alan M. Yahanda, Lawrence A. Donehower and Mitchel Berger. (1994). Basic fibroblast growth factor and fibroblast growth factor receptor I are implicated in the growth of human astrocytomas. Journal of neuro-oncology, 18, 207-216.
Roberto R. Rosato, J. A. A., and Steven Grant. (2003). The histone deacetylase inhibitor MS-275 promotes differentiation or apoptosis in human leukemia cells through a process regulated by generation of reactive oxygen species and induction of p21CIP1/WAF1 1. Cancer research, 63, 3637-3645.
Roberts, W. G., & Palade, G. E. (1995). Increased microvascular permeability and endothelial fenestration induced by vascular endothelial growth factor. Journal of Cell Science, 108(6), 2369-2379.
Russo, M., Spagnuolo, C., Tedesco, I., & Russo, G. L. (2010). Phytochemicals in Cancer Prevention and Therapy: Truth or Dare? Toxins (Basel), 2(4), 517-551.
Russo, M., Tedesco, I., Iacomino, G., Palumbo, R., Galano, G., & Russo, G. (2005). Dietary phytochemicals in chemoprevention of cancer. Current Medicinal Chemistry-Immunology, Endocrine & Metabolic Agents, 5(1), 61-72.
Sathornsumetee, S., & Reardon, D. A. (2009). Targeting multiple kinases in glioblastoma multiforme.
Sathornsumetee, S., Reardon, D. A., Desjardins, A., Quinn, J. A., Vredenburgh, J. J., & Rich, J. N. (2007). Molecularly targeted therapy for malignant glioma. Cancer, 110(1), 13-24.
Sathornsumetee, S., & Rich, J. N. (2008). Designer therapies for glioblastoma multiforme. Annals of the New York Academy of Sciences, 1142(1), 108-132.
Sato, H., & Takino, T. (2010). Coordinate action of membrane‐type matrix metalloproteinase‐1 (MT1‐MMP) and MMP‐2 enhances pericellular proteolysis and invasion. Cancer science, 101(4), 843-847.
Scherer, H. (1940). The forms of growth in gliomas and their practical significance. Brain, 63(1), 1-35.
Schwartz, G. K., & Shah, M. A. (2005). Targeting the cell cycle: a new approach to cancer therapy. Journal of Clinical Oncology, 23(36), 9408-9421.
Shan, T., Ma, Q., Guo, K., Liu, J., Li, W., Wang, F., & Wu, E. (2011). Xanthones from mangosteen extracts as natural chemopreventive agents: potential anticancer drugs. Current molecular medicine, 11(8), 666.
Shih, Y.-W., Chien, S.-T., Chen, P.-S., Lee, J.-H., Wu, S.-H., & Yin, L.-T. (2010). α-Mangostin suppresses phorbol 12-myristate 13-acetate-Induced MMP-2/MMP-9 expressions via αvβ3 Integrin/FAK/ERK and NF-κB signaling pathway in human lung adenocarcinoma A549 Cells. Cell biochemistry and biophysics, 58(1), 31-44.
Siddiqui, I. A., Adhami, V. M., Saleem, M., & Mukhtar, H. (2006). Beneficial effects of tea and its polyphenols against prostate cancer. Molecular nutrition & food research, 50(2), 130-143.
Singh, M., & Singh, N. (2009). Molecular mechanism of curcumin induced cytotoxicity in human cervical carcinoma cells. Molecular and cellular biochemistry, 325(1), 107-119.
Son, T. G., Camandola, S., & Mattson, M. P. (2008). Hormetic dietary phytochemicals. Neuromolecular medicine, 10(4), 236-246.
Sporn, M. B. (1976). Approaches to prevention of epithelial cancer during the preneoplastic period. Cancer research, 36(7 Part 2), 2699-2702.
Sunayama, J., Matsuda, K., Sato, A., Tachibana, K., Suzuki, K., Narita, Y., Kitanaka, C. (2010). Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells. Stem Cells, 28(11), 1930-1939.
Surh, Y. J. (1999). Molecular mechanisms of chemopreventive effects of selected dietary and medicinal phenolic substances. Mutation Research/Fundamental and Molecular Mechanisms of Mutagenesis, 428(1), 305-327.
Surh, Y. J. (2003). Cancer chemoprevention with dietary phytochemicals. Nature Reviews Cancer, 3(10), 768-780.
Surh, Y. J. (2008). NF-κB and Nrf2 as potential chemopreventive targets of some anti-inflammatory and antioxidative phytonutrients with anti-inflammatory and antioxidative activities. Asia Pac J Clin Nutr, 17(Suppl 1), 269-272.
Thakur, V. S., Gupta, K., & Gupta, S. (2012). The chemopreventive and chemotherapeutic potentials of tea polyphenols. Current pharmaceutical biotechnology, 13(1), 191.
Thomas GM, H. R. (2004). MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci., 5, 173-183.
Thompson, C. B. (1995). Apoptosis in the pathogenesis and treatment of disease. Science, 267, 1456-1462.
Tseng, C. H., Chen, Y. L., Lu, P. J., Yang, C. N., & Tzeng, C. C. (2008). Synthesis and antiproliferative evaluation of certain indeno[1,2-c]quinoline derivatives. [Research Support, Non-U.S. Gov't]. Bioorg Med Chem, 16(6), 3153-3162.
Tuteja, N., Singh, M. B., Misra, M. K., Bhalla, P. L., & Tuteja, R. (2001). Molecular mechanisms of DNA damage and repair: progress in plants. Critical Reviews in Biochemistry and Molecular Biology, 36(4), 337-397.
Valko, M., Leibfritz, D., Moncol, J., Cronin, M. T., Mazur, M., & Telser, J. (2007). Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol, 39(1), 44-84.
Vauzour, D., Rodriguez-Mateos, A., Corona, G., Oruna-Concha, M. J., & Spencer, J. P. E. (2010). Polyphenols and human health: prevention of disease and mechanisms of action. Nutrients, 2(11), 1106-1131.
Watson, W. H., Cai, J., & Jones, D. P. (2000). Diet and apoptosis. Annual review of nutrition, 20(1), 485-505.
Wilken, R., Veena, M. S., Wang, M. B., & Srivatsan, E. S. (2011). Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma. Mol Cancer, 10(12), 1-19.
Wittekind, C., & Neid, M. (2005). Cancer invasion and metastasis. Oncology, 69(1), 14-16.
Woodhouse, E. C., Chuaqui, R. F., & Liotta, L. A. (1997). General mechanisms of metastasis. Cancer, 80(S8), 1529-1537.
Yang, C. S., Landau, J. M., Huang, M. T., & Newmark, H. L. (2001). Inhibition of carcinogenesis by dietary polyphenolic compounds. Annual review of nutrition, 21(1), 381-406.
Yang GY, L. J., Li C, Chung J, Yurkow EJ, Ho CT, Yang CS. (2000). Effect of black and green tea polyphenols on c-jun phosphorylation and H(2)O(2) production in transformed and non-transformed human bronchial cell lines: possible mechanisms of cell growth inhibition and apoptosis induction. Carcinogenesis., 21, 2035-2039.
Zülch, K. J. (1986). Brain tumors: their biology and pathology: Springer-Verlag Berlin.
Zhao YL, C. Y., Tzeng CC, Chen IL, Wang TC, Han CH. (2005). Synthesis and cytotoxic evaluation of certain 4-(phenylamino)furo[2,3-b]quinoline and 2-(furan-2-yl)-4-(phenylamino)quinoline derivatives. Chem Biodivers., 2, 205-214.
論文全文使用權限
  • 同意授權校內瀏覽/列印電子全文服務,於2014-01-01起公開。
  • 同意授權校外瀏覽/列印電子全文服務,於2013-08-14起公開。


  • 如您有疑問,請聯絡圖書館
    聯絡電話:(06)2757575#65773
    聯絡E-mail:etds@email.ncku.edu.tw